These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9533761)

  • 1. Comparative study on the induction of cytostasis and apoptosis by ICI 182,780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.
    Ercoli A; Scambia G; Fattorossi A; Raspaglio G; Battaglia A; Cicchillitti L; Malorni W; Rainaldi G; Benedetti Panici P; Mancuso S
    Int J Cancer; 1998 Mar; 76(1):47-54. PubMed ID: 9533761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of cisplatin and ICI 182,780 on estrogen receptor negative ovarian cancer cells: cell cycle and cell replication rate perturbation, chromatin texture alteration and apoptosis induction.
    Ercoli A; Battaglia A; Raspaglio G; Fattorossi A; Alimonti A; Petrucci F; Caroli S; Mancuso S; Scambia G
    Int J Cancer; 2000 Jan; 85(1):98-103. PubMed ID: 10585591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy.
    Bursch W; Ellinger A; Kienzl H; Török L; Pandey S; Sikorska M; Walker R; Hermann RS
    Carcinogenesis; 1996 Aug; 17(8):1595-607. PubMed ID: 8761415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P; Smolnikar K; Michna H
    Breast Cancer Res Treat; 1999 Nov; 58(2):87-97. PubMed ID: 10674872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-estrogens induce apoptosis of multiple myeloma cells.
    Treon SP; Teoh G; Urashima M; Ogata A; Chauhan D; Webb IJ; Anderson KC
    Blood; 1998 Sep; 92(5):1749-57. PubMed ID: 9716605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
    Obrero M; Yu DV; Shapiro DJ
    J Biol Chem; 2002 Nov; 277(47):45695-703. PubMed ID: 12244117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.
    Zalcberg JR; Hu XF; Ching M; Wakeling A; Wall DM; Marschner IC; de Luise M
    Cancer Chemother Pharmacol; 1993; 33(2):123-9. PubMed ID: 7903222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R; Scambia G; Benedetti Panici P; Fattorossi A; Bonanno G; Ferlini C; Isola G; Pernisco S; Mancuso S
    Int J Cancer; 1996 Nov; 68(3):340-8. PubMed ID: 8903476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR; Kang Y; Greaves BR
    Br J Cancer; 1995 Dec; 72(6):1441-6. PubMed ID: 8519657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCF-7 human mammary adenocarcinoma cell death in vitro in response to hormone-withdrawal and DNA damage.
    Wilson JW; Wakeling AE; Morris ID; Hickman JA; Dive C
    Int J Cancer; 1995 May; 61(4):502-8. PubMed ID: 7759156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
    Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
    Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism.
    Mercier I; Mader S; Calderone A
    Cardiovasc Res; 2003 Oct; 59(4):883-92. PubMed ID: 14553828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y; Cortina R; Perry RR
    J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells.
    Perry RR; Kang Y; Greaves B
    Ann Surg Oncol; 1995 May; 2(3):238-45. PubMed ID: 7641021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine inhibits autophagy to potentiate antiestrogen responsiveness in ER+ breast cancer.
    Cook KL; Wärri A; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Clarke R
    Clin Cancer Res; 2014 Jun; 20(12):3222-32. PubMed ID: 24928945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
    Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
    Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.